Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$8.77 - $10.85 $91,690 - $113,436
10,455 New
10,455 $113,000
Q4 2022

Feb 02, 2023

SELL
$8.72 - $11.56 $102,146 - $135,413
-11,714 Reduced 43.63%
15,132 $168,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $63,031 - $82,729
7,433 Added 38.29%
26,846 $229,000
Q2 2022

Aug 03, 2022

SELL
$9.95 - $12.27 $606 - $748
-61 Reduced 0.31%
19,413 $203,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $19,001 - $29,829
-1,937 Reduced 9.05%
19,474 $212,000
Q4 2021

Feb 09, 2022

BUY
$12.09 - $14.68 $258,858 - $314,313
21,411 New
21,411 $290,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Wealth Effects LLC Portfolio

Follow Wealth Effects LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.